MiNK Therapeutics, Inc. (a Delaware corporation) 3,333,334 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • October 28th, 2021 • Agenus Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledOctober 28th, 2021 Company Industry Jurisdiction